CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes
Author
Abstract
Suggested Citation
DOI: 10.1038/s41467-024-45221-2
Download full text from publisher
References listed on IDEAS
- Louai Labanieh & Crystal L. Mackall, 2023. "CAR immune cells: design principles, resistance and the next generation," Nature, Nature, vol. 614(7949), pages 635-648, February.
- Robbie G. Majzner & Sneha Ramakrishna & Kristen W. Yeom & Shabnum Patel & Harshini Chinnasamy & Liora M. Schultz & Rebecca M. Richards & Li Jiang & Valentin Barsan & Rebecca Mancusi & Anna C. Geraghty, 2022. "GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas," Nature, Nature, vol. 603(7903), pages 934-941, March.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Guillem Pascual-Pasto & Brendan McIntyre & Margaret G. Hines & Anna M. Giudice & Laura Garcia-Gerique & Jennifer Hoffmann & Pamela Mishra & Stephanie Matlaga & Simona Lombardi & Rawan Shraim & Patrick, 2024. "CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastoma," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
- Rocío Castellanos-Rueda & Raphaël B. Roberto & Florian Bieberich & Fabrice S. Schlatter & Darya Palianina & Oanh T. P. Nguyen & Edo Kapetanovic & Heinz Läubli & Andreas Hierlemann & Nina Khanna & Sai , 2022. "speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
- Irene Andreu-Saumell & Alba Rodriguez-Garcia & Vanessa Mühlgrabner & Marta Gimenez-Alejandre & Berta Marzal & Joan Castellsagué & Fara Brasó-Maristany & Hugo Calderon & Laura Angelats & Salut Colell &, 2024. "CAR affinity modulates the sensitivity of CAR-T cells to PD-1/PD-L1-mediated inhibition," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
- Derek Lee & Zachary Spencer Dunn & Wenbin Guo & Carl J. Rosenthal & Natalie E. Penn & Yanqi Yu & Kuangyi Zhou & Zhe Li & Feiyang Ma & Miao Li & Tsun-Ching Song & Xinjian Cen & Yan-Ruide Li & Jin J. Zh, 2023. "Unlocking the potential of allogeneic Vδ2 T cells for ovarian cancer therapy through CD16 biomarker selection and CAR/IL-15 engineering," Nature Communications, Nature, vol. 14(1), pages 1-19, December.
- Justin A. Guerrero & Dorota D. Klysz & Yiyun Chen & Meena Malipatlolla & Jameel Lone & Carley Fowler & Lucille Stuani & Audre May & Malek Bashti & Peng Xu & Jing Huang & Basil Michael & Kévin Contrepo, 2024. "GLUT1 overexpression in CAR-T cells induces metabolic reprogramming and enhances potency," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-45221-2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.